BlackRock Advisors’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$2.35M Buy
92,890
+25,725
+38% +$571K ﹤0.01% 1427
2016
Q3
$1.33M Buy
67,165
+43,839
+188% +$766K ﹤0.01% 1669
2016
Q2
$333K Buy
23,326
+2,066
+10% +$31.6K ﹤0.01% 2338
2016
Q1
$330K Buy
21,260
+16,508
+347% +$237K ﹤0.01% 2288
2015
Q4
$82K Sell
4,752
-1,232
-21% -$17.8K ﹤0.01% 3005
2015
Q3
$73K Sell
5,984
-6,010
-50% -$77.1K ﹤0.01% 3209
2015
Q2
$145K Buy
+11,994
New +$118K ﹤0.01% 2993

Other funds holding LMAT

BlackRock Advisors's LMAT Position: Q4 2016 in Review

BlackRock Advisors increased its LeMaitre Vascular (LMAT) stake by 38% in Q4 2016, buying an estimated $571K and bringing the position to 92,890 shares worth $2.35M. The position accounts for ﹤0.01% of the portfolio, ranked #1427.

BlackRock Advisors first reported a position in LMAT in Q2 2015 and has held it in 7 quarters since. 112 funds tracked by Wall St. Rank hold LMAT as of Q4 2016.

  • BlackRock Advisors held 92,890 shares of LeMaitre Vascular worth $2.35M as of Q4 2016.
  • BlackRock Advisors bought 25,725 LeMaitre Vascular shares in Q4 2016, an estimated $571K.
  • LeMaitre Vascular made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #1427 holding.
  • BlackRock Advisors first reported a position in LeMaitre Vascular in Q2 2015 and has held it in 7 quarters since.
  • 112 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.